An important focus of our work is spreading strategies for implementing opioid and pain management best practices. Both naloxone and medications for opioid use disorder, such as buprenorphine, are proven to save the lives of opioid users.
- An overview of the Opioid and Pain Management Best Practices Assessment
- How the results are used to identify quality improvement opportunities.
This event featured the authors of an initiative, recently published in the American Journal of Addiction. The initiative increased naloxone availability for patients with opioid prescriptions within their health system.
Additionally, we hosted a nursing home consultant pharmacist, who shared processes for implementing a medication-assisted therapy program for opioid use disorder in nursing homes.